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Abstract
Caenorhabditis elegans, especially the N2 isolate, is an invaluable biological model system. Numerous additional natural C.
elegans isolates have been shown to have unexpected genotypic and phenotypic variations which has encouraged
researchers to use next generation sequencing methodology to develop a more complete picture of genotypic variations
among the isolates. To understand the phenotypic effects of a genomic variation (GV) on a single gene, in a variation-rich
genetic background, one should analyze that particular GV in a well understood genetic background. In C. elegans, the
analysis is usually done in N2, which requires extensive crossing to bring in the GV. This can be a very time consuming
procedure thus it is important to establish a fast and efficient approach to test the effect of GVs from different isolates in N2.
Here we use a Mos1-mediated single-copy insertion (MosSCI) method for phenotypic assessments of GVs from the variation-
rich Hawaiian strain CB4856 in N2. Specifically, we investigate effects of variations identified in the CB4856 strain on tac-1
which is an essential gene that is necessary for mitotic spindle elongation and pronuclear migration. We show the
usefulness of the MosSCI method by using EU1004 tac-1(or402) as a control. or402 is a temperature sensitive lethal allele
within a well-conserved TACC domain (transforming acidic coiled-coil) that results in a leucine to phenylalanine change at
amino acid 229. CB4856 contains a variation that affects the second exon of tac-1 causing a cysteine to tryptophan change
at amino acid 94 also within the TACC domain. Using the MosSCI method, we analyze tac-1 from CB4856 in the N2
background and demonstrate that the C94W change, albeit significant, does not cause any obvious decrease in viability.
This MosSCI method has proven to be a rapid and efficient way to analyze GVs.
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Introduction
C. elegans is central to biomedical, molecular, cell and de-
velopmental biology research, and is among the best genetically
and molecularly characterized and understood model organisms.
The most studied and the best understood C. elegans strain is N2,
which was obtained from mushroom compost in Bristol, England
[1]. The genome of N2 was the first one of a multi-cellular animal
that has been fully sequenced and published [2]. While N2 has
been widely used in research as a model organism for the past 40
years [3] other C. elegans wild-strains have been isolated globally
from human-associated habitats such as rotting fruits and compost
heaps [3,4]. With the goal of reaching a better understanding of
genotypic and phenotypic differences between these strains, as well
as studying the relationships between genetic interactions, the wild
isolates have been subjected to either whole [5] or partial genome
sequencing [4]. Genetic studies of different C. elegans wild-strains
[4,6,7,8,9] have revealed little genetic diversity compared to
closely related species [4,7,8,9,10,11,12,13,14,15,16,17], yet com-
parable to genetic diversity among human populations [18].
CB4856, which was isolated in 1972 from a pineapple field in
Hawaii [19], is the wild-isolate strain that has been most
extensively compared to N2 both genetically and phenotypically.
In addition to the large number of genome variations (small and
large changes in DNA sequence) between N2 and CB4856
[20,21,22,23,24], a number of phenotypic differences between the
strains have been described. For example, CB4856 contains
multiple variations in a PAZ/PIWI domain-containing protein
(ppw-1) which renders the Hawaiian strain resistant to effecting
germline-expressed genes when feeding dsRNA directed against
those genes [25]. Recently CB4856 was found to be resistant to
avermectins due to a four-amino-acid deletion in the ligand-
binding domain of GLC-1, the alpha-subunit of a glutamate-gated
chloride channel [26]. Identification of this naturally occurring
four-amino-acid deletion in GLC-1 of the Hawaiian strain is the
first genetic evidence of a mechanism for nematode resistance to
anthelmintics, this type of resistance, in many nematode species,
represents a major global health and agricultural problem [26].
Genome variations (GVs) for other phenotypic differences
between the two strains have been identified although some traits
including egg-laying behaviour and vulva development do not
have identified genetic bases. To identify a variation responsible
for a particular phenotype in a variation-rich natural isolate like
CB4856, one would typically introduce GVs into the N2 genetic
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background to follow the observable trait in order to map it to
a chromosomal region. Alternatively, whole genome sequencing
allows for a candidate gene approach in which a candidate
variation for a particular trait is introduced into the well
understood N2 background after extensive outcrossing and scored
for a visible phenotype. However, the outcrossing procedure can
be extremely time consuming and particularly difficult when the
phenotypes are subtle or when the GVs cannot be followed using
PCR or PCR followed by restriction enzyme digests. Overcoming
these difficulties and establishing fast and efficient approaches for
analyzing phenotypes of candidate GVs from the variation-rich
strains in the N2 background is essential for analysis of phenotypic
differences between the strains.
Mos1-mediated single-copy insertion (MosSCI) is a recently
developed method in C. elegans that allows integration of transgenes
as single copies at a defined genomic site [27]. MosSCI eliminates
problems associated with common methods for generating
transgenes in C. elegans, including concatenation of injected
DNA, as well as formation of multicopy arrays that are over-
expressed in somatic cells and silenced in the germline [27].
Furthermore genetically neutral Mos1 insertion alleles exist that
allow expression of transgenes at endogenous levels [27,28].
Recently we demonstrated a powerful aspect of the MosSCI
method that allows us to increase gene copy number in a controlled
fashion and analyze the consequence of doubling [28] or tripling
[29] gene dosage on animal development in different genetic
backgrounds. In this study we examined how genome variations
affecting an essential gene from CB4856 behave in N2 using the
MosSCI method. We examined GVs affecting an essential gene
tac-1 [30,31,32,33]. We demonstrated the power of the method by
phenocopying the lethal phenotype of tac-1(or402) from EU1004
strain [33]. Importantly, we showed that the non-synonymous
radical change within the essential TACC domain does not cause
an apparent decrease in viability in the N2 background. The
protocol we describe here is fast and efficient for analysis of single-
gene variations from variation-rich C. elegans strains in the
extensively studied N2 background. Furthermore, this protocol is
effective for ruling out lack of readily detectable phenotypes due to
a presence of putative modifiers.
Materials and Methods
Strains and Culturing Conditions
The following mutant alleles were used in this work: unc-
119(ed3), cxTi10882, or368/or402, ok3305, dpy-10(e128), and mT1.
The following strains were used in this work: N2 (Bristol strain as
a wild-type), EU1004 [tac-1(or402) II], CB4856, EG6250 [unc-
119(ed3) III; cxTi10882 IV] and VC2580 [tac-1(ok3305)/mT1 II; +/
mT1[dpy-10(e128)] III ]. The alleles dotSi120 and dotSi121, and
JNC150 [dotSi120 IV [Y54E2A.3CB4856 + unc-119(+)]], JNC151
[(tac-1(ok3305) II; dotSi120 IV [Y54E2A.3CB4856 + unc-119(+)]],
JNC152 [dotSi121 IV [Y54E2A.3EU1004 + unc-119(+)]] and JNC153
[tac-1(ok3305) II; dotSi121 IV [Y54E2A.3EU1004 + unc-119(+)]]
strains were generated in this study. All strains were maintained
using standard protocol on nematode growth media (NGM) plates
seeded with OP50 bacteria [34]. Strains were maintained at 20uC
while phenotypic analyses were performed at both 14uC and 25uC
as noted in the manuscript.
Mos1-mediated transgenesis
The tac-1 locus was amplified using Phusion (NEB), high-fidelity
DNA polymerase from either CB4856 or EU1004 single worm
lysates. The following primers were used: FORWARD- AAACTAT-
TACCTTCGCCTTCGC and REVERSE-CTGGAAAATTGCAA-
GATTTTAATAG. Amplicons were cloned into the pCFJ178
vector, as described previously [27]. Similar to our previous
findings using the essential cell cycle gene cyb-3 [28,29], we have
also found that tac-1, when injected in high concentrations, results
in a toxic effect. Thus to obtain stable single-copy insertions, we
co-injected 5 ng/ml of tac-1-targetting constructs with 50 ng/mL of
pJL43.1, 5 ng/mL pGH8, 5 ng/mL pCFJ104 and 2.5 ng/mL
pCFJ90 into the gonad of 32 (tac-1CB4856) and 38 (tac-1EU1004)
young adult P0 EG6250 hermaphrodites. The plates that
contained wild-type looking mCherry expressing worms were
starved at 25uC and then screened for stable integrants as
previously described [27]. Within two weeks multiple stable lines
were obtained for each construct. One of each was confirmed to
contain a single, truncation-free, integration at the cxTi10882 site.
These were further analyzed as JNC150 (tac-1CB4856) and JNC152.
(tac-1EU1004). Neither of these strains have any obvious increase in
lethality or developmental delay when observed at 14uC, 20uC
and 25uC (Table 1 and data not shown).
Analysis of the ok3305 knockout allele
ok3305 is a 812bp deletion that removes the majority of the tac-1
gene. Previously, the loss of TAC-1 was mainly studied using
RNAi to deplete the tac-1 product [30,31,32]. In the absence of
TAC-1 progeny arrest as embryos due to defective microtubule
formation [30,31,32]. The knockout allele, tac-1(ok3305), also
results in lethality and so it was kept balanced as a heterozygote
over a translocation (mT1). However, the stage at which tac-
1(ok3305) homozygotes arrest has not been determined previously.
In this study, we analyzed VC2580 to determine ok3305’s
phenotype. We found that VC2580 segregates approximately
63% arrested embryos due to mT1 translocation aneuploidies,
,6% of mT1 homozygotes are Dpy and sterile, ,6% are wild-
type looking tac-1(ok3305) progeny and 25% are tac-1(ok3305)/
mT1 II; +/mT1[dpy-10(e128)] III heterozygotes. Analysis of the
,6% of the tac-1(ok3305) homozygotes, segregated from tac-
1(ok3305)/mT1 II; +/mT1[dpy-10(e128)] III heterozygous her-
maphrodites, revealed that all tac-1(ok3305) homozygotes produce
progeny of which 100% arrest as embryos (Table 1). This is
a common phenotype for maternal effect genes. Namely, F1 tac-
1(ok3305) homozygotes likely receive the TAC-1 protein from tac-
1(ok3305)/mT1 II; +/mT1[dpy-10(e128)] heterozygous hermaph-
rodites that allows them to develop into adult animals. However,
the F2 generation of tac-1(ok3305) homozygotes does not have any
wild-type TAC-1, which leads to 100% embryonic arrest. This
phenotype is similar to the phenotype observed when RNAi is
used to deplete TAC-1 [30,31,32]. Thus, we conclude that TAC-1
is likely to be maternally supplied and that loss of TAC-1 results in
maternal effect embryonic lethality.
Use of the ok3305 knockout allele in phenotypic analysis
of tac-1 GVs
First, we generated JNC150 and JNC152 males by heat shock.
These males were then mated to tac-1(ok3305) homozygotes to
generate JNC151 [(tac-1(ok3305) II; dotSi120 IV [Y54E2A.3CB4856 +
unc-119(+)]] and JNC153 [tac-1(ok3305) II; dotSi121 IV
[Y54E2A.3EU1004 + unc-119(+)]]. Unlike tac-1(ok3305) homozy-
gotes, which arrest as embryos, JNC151 homozygotes are
indistinguishable from N2 (Table 1), while JNC153 homozygotes
are indistinguishable from EU1004 (Table 1).
Phenotypic analysis
For each analysis, L4 hermaphrodites were grown on fresh
OP50 plates at 14uC or 25uC. The hermaphrodites were
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transferred to fresh plates every 12 hours. Eggs that did not hatch
were scored as embryonic arrest, while eggs that hatched but did
not grow to adulthood were scored as larval arrest. Together,
embryonic and larval arrest are reported as developmental arrest
in Table 1.
Results and Discussion
Recently we used whole-genome sequencing to identify GVs
that disrupt protein-coding genes in CB4856 which is a wild-
isolate strain of C. elegans from Hawaii (Vergara, Tarailo-Graovac,
et al. in preparation). We were particularly interested in variations
that are expected to cause a significant disruption of essential
protein-coding genes. One such variation was identified within tac-
1 and we wanted to test the phenotype of this variation in the N2
background. tac-1 is an essential gene and the only member of the
transforming acidic coiled-coil (TACC) protein family in C. elegans
whose function is crucial for pronuclear migration and mitotic
spindle elongation [30,31,32]. In CB4856 we identified a number
of single nucleotide changes that affect tac-1. In particular, one
variation affected the second exon of tac-1 causing a C94W change
in the amino acid sequence (Figure 1a). To date, three point
mutant alleles of tac-1 have been isolated in genetic screens for
temperature-sensitive mutants using EMS mutagenesis [33] in
addition to one knockout allele. Both tac-1(or369) and tac-1(or402)
have the same mutation in the TACC domain that results in
a L229F amino acid change [33]. tac-1(or455) has a M58I change
in the TACC domain [33]. Both of the amino acid changes occur
within residues that are not highly conserved, yet the impact of
these mutations is significant [33]. Both tac-1(or369/or402) and tac-
1(or455) are temperature sensitive alleles and result in .95%
embryonic arrest at a restrictive temperature [33]. Similar to these
point mutations isolated in tac-1, the C94W change occurs in the
essential TACC domain (Figure 1a) but also does not affect
a highly conserved residue (Figure 1b). Since the C94W variation
results in cysteine, which is polar amino acid, being replaced by
the non-polar amino acid tryptophan, the C94W change would be
considered more radical than either the L229F or the M58I
changes, yet CB4856 animals do not have a temperature sensitive
phenotype as the EMS-derived point mutants do. Thus, we were
interested to see whether the lack of phenotype may be due to
a presence of modifying mutations in CB4856 or simply because
the C94W change does not affect TAC-1 function while the
L229F and M58I changes do. Inspired by the enormous potential
of the recently developed MosSCI method [27], which allowed us
to show that doubling the dosage of the Cyclin B3 in C. elegans
bypasses the need for the functional spindle-assembly checkpoint
component MDF-1/Mad1 for survival beyond the third genera-
tion [28,29], we decided to investigate an effect of GVs detected in
CB4856 within tac-1 in the N2 background using the MosSCI
method (Figures 1 and 2).
The MosSCI method relies on the presence of a Mos1 insertion
at the specific locus in C. elegans genome [27]. A large collection of
mapped Mos1 insertion alleles has been generated by the
European NEMAGENETAG consortium [35]. Many of the
Mos1 insertions were identified as ‘‘genetically neutral’’ (inserted
within genomic regions 39 to coding genes) and shown to have
robust germline expression [27,36]. Previously, we successfully
used the ttTi5605 [28] and cxTi10882 [29] Mos1 insertions, which
are located at the center of chromosomes II and IV respectively, to
study effects of cyb-3 dosage on C. elegans development and
anaphase onset [28,29]. Neither of these Mos1 insertions
interfered with the proper function of the inserted cyb-3 gene
[28,29]. For the analysis of the GVs affecting tac-1, we selected the
cxTi10882 Mos1 insertion because it is located on different
chromosome than tac-1 [27,36]. Since cxTi10882 is located at the
centre of chromosome IV and natural tac-1 position is at the distal
end of chromosome II, inserting tac-1 into the cxTi10882Mos1 site
should place it in a different genomic environment [37]. Namely,
individual autosomes as well as chromosome arms and centers
differ in several important properties including content of highly
expressed genes, repetitive elements, and chromatin composition
[37]. To test the cxTi10882 Mos1 insertion site and the method we
asked whether the temperature sensitive phenotype of tac-1(or402)
allele could be phenocopied using this approach. We amplified tac-
1 including 59 sequence immediately upstream of the predicted
ATG initiator site and 39 sequence immediately downstream of
the predicted stop codon, from EU1004 (Figure 2a). Then, we
cloned the tac-1 amplicon into the pCFJ178 vector and inserted
the transgene into the cxTi10882 Mos1 integration site (Figure 2a).
The strain that we generated contains an N2 copy of tac-1 located
at its endogenous position on chromosome II, as well as the
chromosome IV integrated copy of EU1004 tac-1 (dotSi121) that
encodes the L229F change (Figure 2a). To uncover the effects of
the L229F change, tac-1 (dotSi121) must be analyzed in the absence
of the endogenous tac-1 gene product.
tac-1(ok3305) is an 812 bp deletion that removes the majority of
tac-1 (part of exon one, and exons two and three) and is likely to be
a null mutation. To analyze ok3305 we performed detailed
phenotypic analysis (see MATERIALS AND METHODS). Our
analysis revealed that tac-1(ok3305) results in maternal effect
embryonic arrest. Namely, F1 tac-1(ok3305) homozygotes likely
receive wild-type TAC-1 protein from tac-1 heterozygous P0s that
allows them to develop into adult animals. However, F2
homozygotes do not have any wild-type TAC-1, which leads to
100% of embryonic arrests (Table 1). The embryonic arrest
phenotype is putatively identical to the phenotype observed when
Table 1. Phenotypes of tac-1 alleles.
Genotypes Developmental arrests 14uC (%) Developmental arrests 25uC (%)
N2 (reference) 0.8 (n= 1441) 1.4 (n=1987)
dotSi120 IV [Y54E2A.3CB4856 + unc-119(+)] 0.6 (n= 1596) 1.2 (n=1902)
dotSi121 IV [Y54E2A.3EU1004 + unc-119(+)] 0.4 (n= 1844) 1.5 (n=1157)
EU1004 [tac-1(or402) II] 64.9 (n= 336) 94.9 (n=295)
tac-1(ok3305) II (F2) 100 (n=445) 100 (n= 394)
tac-1(ok3305) II; dotSi120 IV [Y54E2A.3CB4856 + unc-119(+)] 0.6 (n= 1647) 1.2 (n=1714)
tac-1(ok3305) II; dotSi121 IV [Y54E2A.3EU1004 + unc-119(+)] 61.2 (n= 276) 94.4 (n=697)
doi:10.1371/journal.pone.0048762.t001
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Figure 1. The C94W change is within the TACC domain. (a) Schematic representation of TAC-1 (1 to 260 amino-acid sequence). The majority of
the protein is composed of the TACC domain which is depicted by the cyan box. Location and nature of all of the point mutants identified to date are
shown as well. The ok3305 knockout allele, which removes the majority of tac-1 is depicted using a pink box. (b) The multiple sequence alignment of
TAC-1 was adopted from Bellanger et al. 2007 [33]. The positions of the previously isolated point mutants tac-1(or455) and tac-1(or369/402) are
depicted using red stars, while the C94W change identified in CB4856 is depicted using a red arrow. The cyan box highlights the presence of the
TACC domain. All of the known point mutations occur within the TACC domain, but none of them affect conserved amino acids.
doi:10.1371/journal.pone.0048762.g001
Figure 2. A single-copy transgene insertion used to investigate consequences of single gene mutations in variation-rich isolates of
C. elegans. (a) Analysis of tac-1(or402) using Mos1-mediated transgenesis. tac-1, including its 59 and 39 regulatory sequences, was amplified using
high-fidelity DNA polymerase from EU1004 genomic DNA and cloned into a pCFJ178 vector. The red dotted line located in the third exon of tac-1
depicts the or369/402 A to G change that results in an L229F amino acid change. Once cloned into the pCFJ178 vector, the transgene was inserted
into the cxTi10882 Mos1 (depicted in orange) integration site on chromosome IV (depicted in purple). The resulting JNC152 strain contains both the
endogenous copy of tac-1 located on chromosome II (depicted in blue), and tac-1 isolated from EU1004 inserted on chromosome IV, dotSi121. To
uncover the effect of tac-1(or402), dotSi121 was examined in the absence of endogenous TAC-1 using ok3305. Thus, we constructed JNC153. (b)
Schematic representation of the method used to investigate consequences of tac-1 variations detected in CB4856 tac-1, including the 59 and 39
regulatory sequences, was amplified using high-fidelity DNA polymerase from CB4856 genomic DNA and cloned into a pCFJ178 vector. The red
dotted lines represent single nucleotide changes detected in CB4856 tac-1. Then, the transgene was inserted into the cxTi10882 Mos1 (depicted in
orange) integration site on chromosome IV (depicted in purple). JNC150 contains both the endogenous copy of tac-1 located on chromosome II
(depicted in blue) and tac-1 isolated from CB4856 dotSi120 inserted on chromosome IV. Then, dotSi120 was analyzed in the absence of endogenous
tac-1(ok3305). (c) PCR bands of the expected size (6kb) for stably integrated single copy insertions of tac-1, dotSi121 and dotSi120.
doi:10.1371/journal.pone.0048762.g002
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RNAi is used to deplete TAC-1 [30,31,32]. Thus, we conclude
that ok3305 is presumably a null allele of tac-1.
Next, we analyzed tac-1 (dotSi121) in the absence of the
endogenous tac-1 product by using the ok3305 knockout allele
(Figure 2a). Our analysis revealed that the original strain EU1004
tac-1(or368/or402) II and the strain that we created using the
MosSCI method JNC153 tac-1(ok3305) II; dotSi121 IV
[Y54E2A.3EU1004 + unc-119(+)] are indistinguishable (Table 1).
Phenocopying the lethal phenotype of the L229F change strongly
supports the use of the outlined method for analysis of variations
affecting a single gene.
Most heritable traits, including different susceptibility to disease
and different responses to drug treatments, are genetically
complex, resulting from contributions of mutations in many
different genes [38]. Using model organisms, it has been shown
that for the majority of phenotypes [39] and genes [40] the
phenotypic consequence of identical GVs are affected by
modifiers, variations present at other loci in the genome of the
organism [41]. To determine whether the lack of phenotype may
be due to a presence of modifiers in CB4856 or simply because the
cysteine 94 residue is not essential for TAC-1 function, we
analyzed CB4856 GVs affecting tac-1 in the N2 background. In
addition to the variation that results in the C94W amino acid
change (Figure 1), tac-1 has four mutations that are located
upstream and one located downstream of the gene (Figure 2b). To
rule out the possibility that these mutations may affect the
expression of CB4856 tac-1, we investigated data from recent
studies that analyzed differences in gene expression between N2
and CB4856 [42,43]. Based on these data, tac-1 does not appear to
be differentially expressed in CB4865. Thus, to determine the
effect of the C94W change in the N2 background, we decided to
amplify CB4856 tac-1, including its 59 and 39 sequences. We
cloned the amplicon into the pCFJ178 vector and inserted the
transgene into the cxTi10882 Mos1 integration site (Figure 2b).
Then, we analyzed tac-1 (dotSi120) that encodes the C94W change
in the absence of endogenous tac-1 gene product using the
knockout allele (ok3305) (Figure 2b). Unlike L229F, C94W does
not have any obvious effect on viability because 99.4% and 98.8%
of the embryos analyzed at 14uC and 25uC respectively develop
into adults, which is similar to what we have observed in N2 alone
(Table 1). Thus, we were able to show, in a very time-effective
manner, that variations affecting CB4856 tac-1 do not result in an
obvious phenotype that would be expected from a radical change,
such as C94W, affecting the essential gene tac-1. The method
outlined here has allowed us to very efficiently rule out the
hypothesis that lack of a phenotypic consequence in the presence
of C94W is due to putative GVs elsewhere in the CB4856 genome
that modify the effects of the C94W variation. In contrast, these
data suggest that L229 and M58 residues of the TACC domain
are more sensitive to change than the C94 residue.
Conclusion
Understanding the phenotypic consequence of GVs in different
genetic backgrounds is of great importance for understanding
phenotypic variations among individuals, especially disease
susceptibility and treatment. To analyze the impact of GVs on
a single gene and to test for the presence of putative modifiers due
to natural variations, one needs to analyze causative variations in
well understood and established genetic backgrounds. Here, we
show a fast and efficient approach to analyzing GVs from
variation-rich strains in the well-understood C. elegans N2
background. Using this approach, based on the MosSCI method,
desired strains are usually generated within a few weeks.
Alternative approaches that relay on extensive outcrossing usually
take months. In addition to the time-consuming nature of the
alternative approaches, the analysis may further be complicated by
the involvement of other loci in variation rich-strains. For
example, the analysis of CX11307 and JU751 wild-isolate strains
for abamectin resistance, suggested the presence of a putative
dominant resistance factor in addition to the glc-1 variation [26].
Also, the analysis of resistance to dsRNA directed against
germline-expressed genes [25] in CB4856 has suggested the
presence of at least one other modifier allele in CB4856 in addition
to the ppw-1 mutation [25]. Furthermore, in the case of tac-1, an
alternative analysis that relies on extensive outcrossing to place
mutations in N2 would have been difficult due to the lack of
obvious phenotypes and the fact that the C94W point mutation
cannot be followed easily using PCR or even PCR followed by
a restriction enzyme digest. Using the MosSCI method, we were
able to show, in a very time-effective manner that the cysteine to
tryptophan change in amino acid 94 of tac-1 albeit significant, does
not cause any decrease in viability in the N2 background. This
result suggests that lack of phenotype CB4856 is not due to the
presence of putative modifiers. Instead, cysteine at amino acid 94
may not play an important role for the function of the essential
TACC domain and TAC-1. The usefulness of the approach that
we describe in this manuscript also lies in its ability to be applied to
engineer amino acid changes of interest rather than move already
existing variations from one background to another. In such a way,
one can analyze the effect of a specific amino acid on the
development and viability of C. elegans by altering a particular
amino acid. Furthermore, using this approach, genes from
different Caenorhabditis and other species can be analyzed without
having to deal with over-expression issues.
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